Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Brainstorm Cell Therapeut...

    NASDAQ: BCLI · Real-Time Price · USD
    0.60
    0.00 (0.00%)
    At close: Aug 15, 2025, 11:13 AM

    Brainstorm Cell Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 849K n/a n/a n/a
    Cost of Revenue
    		 n/a 265K 285K 260K
    Gross Profit
    		 849K -265K -285K -260K
    Operating Income
    		 n/a -21.44M -24.82M -24.54M
    Interest Income
    		 n/a n/a 545K 82K
    Pretax Income
    		 11.62M -17.19M -24.28M -24.46M
    Net Income
    		 11.62M -17.19M -24.28M -24.46M
    Selling & General & Admin
    		 n/a 10.69M 10.87M 9.3M
    Research & Development
    		 n/a 10.48M 13.96M 15.23M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 n/a 21.17M 24.82M 24.54M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 21.44M 24.82M 24.54M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 5.31M 3.84M 2.45M 2.42M
    Shares Outstanding (Diluted)
    		 5.31M 3.84M 2.45M 2.42M
    EPS (Basic)
    		 2.19 -4.48 -9.93 -10.09
    EPS (Diluted)
    		 2.19 -4.48 -9.93 -10.09
    EBITDA
    		 n/a -16.93M -23.99M -24.28M
    EBIT
    		 n/a -17.19M -24.28M -24.46M
    Depreciation & Amortization
    		 n/a 265K 285K 260K

    Add to Watchlist